Market Indices
Latest News
 |
| ||
| ||
|
Price Targets
Ellie Jiang from Macquarie issued a price target of $44.30 for TCOM on 2026-06-26 01:30:53.The adjusted price target was set to $44.30.At the time of the announcement, TCOM...
June 25, 2026 TCOM -12.55%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| STG Sunlands Technology Group | 4.52
10.51% | ||||||||||||||||||
| QNRX Quoin Pharmaceuticals, Lt | 4.23
10.44% | ||||||||||||||||||
| WAVE Eco Wave Power Global AB | 9.92
9.98% | ||||||||||||||||||
| ASND Ascendis Pharma A/S | 261.58
9.90% | ||||||||||||||||||
| SLN Silence Therapeutics plc | 10.00
9.17% | ||||||||||||||||||
| CMPS COMPASS Pathways plc | 13.58
7.95% | ||||||||||||||||||
| ZEPP Zepp Health Corporation | 4.73
6.18% | ||||||||||||||||||
| CNF CNFinance Holdings Limite | 3.06
5.52% | ||||||||||||||||||
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT -0.49%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA -1.42%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 TEVA -1.42%